|
Thrombosis risk factors
Citations 51-60 of 165 total displayed.
|
Past content
(since Dec 2000):
|
- Vascular Medicine
Effect of Tamoxifen on Venous Thromboembolic Events in a Breast Cancer Prevention Trial
- Andrea Decensi, Patrick Maisonneuve, Nicole Rotmensz, Donato Bettega, Alberto Costa, Virgilio Sacchini, Alessandro Salvioni, Roberto Travaglini, Pasquale Oliviero, Giuseppe D’Aiuto, Marcella Gulisano, Giacomo Gucciardo, Marco Rosselli del Turco, Maria Antonietta Pizzichetta, Serafino Conforti, Bernardo Bonanni, Peter Boyle, Umberto Veronesi for the Italian Tamoxifen Study Group
Circulation 2005;111:650-656, doi:10.1161/01.CIR.0000154545.84124.AC
[Abstract]
[Full text]
- Clinician Update
Prevention of Venous Thromboembolism Among Hospitalized Medical Patients
- Samuel Z. Goldhaber and Alexander G.G. Turpie
Circulation 2005;111:e1-3e, doi:10.1161/01.CIR.0000150393.51958.54
[Full text]
- Prevention of Venous Thromboembolism
Prevention of Recurrent Idiopathic Venous Thromboembolism
- Samuel Z. Goldhaber
Circulation 2004;110:IV-20-24IV-, doi:10.1161/01.CIR.0000150641.65000.f2
[Abstract]
[Full text]
- Vascular Medicine
Factor VLeiden Inhibits Fibrinolysis In Vivo
- Andrew C. Parker, Lakshmi V. Mundada, Alvin H. Schmaier, and William P. Fay
Circulation 2004;110:3594-3598; published online before print as doi:10.1161/01.CIR.0000148781.87906.C0
[Abstract]
[Full text]
- Articles
Factor VLeiden Inhibits Fibrinolysis In Vivo
- Andrew C. Parker, Lakshmi V. Mundada, Alvin H. Schmaier, and William P. Fay
Circulation published November 29, 2004, doi:10.1161/01.CIR.0000148781.87906.C0
[Abstract]
- Clinician Update
Platelet Function Testing in Cardiovascular Diseases
- Alan D. Michelson
Circulation 2004;110:e489-493e, doi:10.1161/01.CIR.0000147228.29325.F9
[Full text]
- Cardiology Patient Pages
Prevention of Deep Vein Thrombosis and Pulmonary Embolism
- Samuel Z. Goldhaber and John Fanikos
Circulation 2004;110:e445-447e, doi:10.1161/01.CIR.0000145141.70264.C5
[Full text]
- Arrhythmia/Electrophysiology
Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin
- Brian F. Gage, Carl van Walraven, Lesly Pearce, Robert G. Hart, Peter J. Koudstaal, B.S.P. Boode, and Palle Petersen
Circulation 2004;110:2287-2292; published online before print as doi:10.1161/01.CIR.0000145172.55640.93
[Abstract]
[Full text]
- Coronary Heart Disease
Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes
- J.P. Collet, G. Montalescot, B. Blanchet, M.L. Tanguy, J.L. Golmard, R. Choussat, F. Beygui, L. Payot, N. Vignolles, J.P. Metzger, and D. Thomas
Circulation 2004;110:2361-2367; published online before print as doi:10.1161/01.CIR.0000145171.89690.B4
[Abstract]
[Full text]
- Articles
Selecting Patients With Atrial Fibrillation for Anticoagulation. Stroke Risk Stratification in Patients Taking Aspirin
- Brian F. Gage, Carl van Walraven, Lesly Pearce, Robert G. Hart, Peter J. Koudstaal, B. S.P. Boode, and Palle Petersen
Circulation published October 11, 2004, doi:10.1161/01.CIR.0000145172.55640.93
[Abstract]
|
|
